Identification of stress degradation products of iloperidone using liquid chromatography coupled with an Orbitrap mass spectrometer.
暂无分享,去创建一个
[1] F. Fernandez‐Llimos,et al. Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy , 2016, Core evidence.
[2] P. Garg,et al. Characterization of stress degradation products of mirabegron using UPLC-QTOF-MS/MS and in silico toxicity predictions of its degradation products , 2015 .
[3] A. Sangamwar,et al. Characterization of degradation products of ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis. , 2015, Journal of mass spectrometry : JMS.
[4] Shashikant B. Landge,et al. Development and Validation of RP-UPLC Method for the Determination of Iloperidone, Its Related Compounds and Degradation Products in Bulk and Dosage Form , 2014 .
[5] R. Srinivas,et al. LC–ESI–MS/MS study of carvedilol and its stress degradation products , 2013 .
[6] Roshan M. Borkar,et al. Liquid chromatography/electrospray ionization tandem mass spectrometric study of milnacipran and its stressed degradation products. , 2013, Rapid communications in mass spectrometry : RCM.
[7] P. Patel,et al. Identification and characterization of stressed degradation products of metoprolol using LC/Q-TOF-ESI-MS/MS and MS(n) experiments. , 2012, Biomedical chromatography : BMC.
[8] G. Reynolds. Receptor mechanisms of antipsychotic drug action in bipolar disorder – focus on asenapine , 2011, Therapeutic advances in psychopharmacology.
[9] Y. Venkateswarlu,et al. Identification and characterization of stressed degradation products of prulifloxacin using LC-ESI-MS/Q-TOF, MSn experiments: development of a validated specific stability-indicating LC-MS method. , 2011, Journal of pharmaceutical and biomedical analysis.
[10] S. Prabhakar,et al. Mass spectral analysis of N-oxides of Chemical Weapons Convention related aminoethanols under electrospray ionization conditions. , 2011, Rapid communications in mass spectrometry : RCM.
[11] G. D. Dal Pan,et al. Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008 , 2010, Pharmacoepidemiology and drug safety.
[12] Karen M. Alsante,et al. A critical assessment of the ICH guideline on photostability testing of new drug substances and products (Q1B): Recommendation for revision. , 2010, Journal of pharmaceutical sciences.
[13] C. Punt,et al. Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death , 2009 .
[14] A. Wheeler,et al. Trends in Antipsychotic Prescribing in Schizophrenia in Auckland , 2006, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists.
[15] W. Ray,et al. Trends in prescribing of antipsychotic medications for US children. , 2006, Ambulatory pediatrics : the official journal of the Ambulatory Pediatric Association.
[16] V. Bhatara,et al. Antipsychotic prescribing trends among youths, 1997-2002. , 2005, Psychiatric services.
[17] B. Bradbury,et al. Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population-based observational study. , 2003, British journal of clinical pharmacology.
[18] W A Ray,et al. Antipsychotics and the risk of sudden cardiac death. , 2001, Archives of general psychiatry.
[19] M. Cornfeldt,et al. The pharmacological profile of iloperidone, a novel atypical antipsychotic agent. , 1995, The Journal of pharmacology and experimental therapeutics.